Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.
A big investment bank believes in Inspire Medical and thinks the stock could be worth more money. When smart experts raise their price targets, it means they see good reasons to stay confident in the company.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.